
ALK-IN-26
CAS No. 2447607-85-2
ALK-IN-26 ( —— )
产品货号. M37104 CAS No. 2447607-85-2
ALK-IN-26 (compound 4a) 是 ALK 抑制剂,对 ALK 酪氨酸激酶的 IC50 值为7.0 μM。ALK-IN-26 有良好的药代动力学特性和血脑屏障通透性。ALK-IN-26 能够引起细胞凋亡、自噬和坏死。ALK-IN-26 能够用于胶质母细胞瘤研究。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥452 | 有现货 |
![]() ![]() |
5MG | ¥638 | 有现货 |
![]() ![]() |
10MG | ¥993 | 有现货 |
![]() ![]() |
25MG | ¥1869 | 有现货 |
![]() ![]() |
50MG | ¥2956 | 有现货 |
![]() ![]() |
100MG | ¥4276 | 有现货 |
![]() ![]() |
500MG | ¥9104 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称ALK-IN-26
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述ALK-IN-26 (compound 4a) 是 ALK 抑制剂,对 ALK 酪氨酸激酶的 IC50 值为7.0 μM。ALK-IN-26 有良好的药代动力学特性和血脑屏障通透性。ALK-IN-26 能够引起细胞凋亡、自噬和坏死。ALK-IN-26 能够用于胶质母细胞瘤研究。
-
产品描述ALK-IN-26 is an ALK inhibitor with IC50 value of 7.0 μM for ALK tyrosine kinase. ALK-IN-26 has good pharmacokinetic properties and blood-brain barrier (BBB) permeability. ALK-IN-26 can induce apoptosis, autophagy and necrosis. ALK-IN-26 can be used in glioblastoma studies.
-
体外实验Apoptosis AnalysisCell Line:GL261 Concentration:0.5 μM, 1.0 μM, 2.0 μM Incubation Time:24 h, 48 h, 72 h Result:Induced apoptosis of glioblastoma in a concentration- and time-dependent manner, and caused the cells (24.5%) entered the S phase but barely proceeded to the G2/M phase when treated with 1 μM for 72 h.Cell Viability AssayCell Line:GL216, U87MG, HelaConcentration:0.5 μM, 1.0 μM, 2.0 μM, 5 μM, 10 μM for GL216 and U87MG cells 5 μM, 10 μM, 20 μM, 40 μM, 80 μM, 160 μM for Hela cells Incubation Time:24 h, 48h, 72h Result:Inhibited the activity of GL216 cells with the inhibition rate of cells at 80% when incubated with 2 μM for 72 h and inhibited U87MG cells viability with a dose- and time-dependent manner, while showed limited inhibition on Hela cells, even at 160 μM, the inhibition rate is less than 50%. Can inhibit the activity of ALK tyrosine kinase with a dose-dependent manner.Cell Autophagy Assay Cell Line:GL261 Concentration:0.5 μM, 1.0 μM, 2.0 μM Incubation Time:24 h Result: Induced autophagy death in glioblastoma cells.
-
体内实验Animal Model:Male C57BL/6J miceDosage:5 mg/kgAdministration:Intravenous injection (i.v.), Single dose Result:Could be rapidly absorbed (Tmax = 0.58 h) with an acceptable half-life (T1/2 = 3.55 h) and bioavailability (F = 38.4%).Animal Model:Male C57BL/6J mice Dosage:20mg/kg Administration:Intraperitoneal injection (i.p.), Single doseResult:Could enter the body at concentrations up to 2.7μmol/kg (after 2 h administration at 20 mg/kg) andpenetrate the blood-brain barrier.
-
同义词——
-
通路Angiogenesis
-
靶点ALK
-
受体ALK
-
研究领域——
-
适应症——
化学信息
-
CAS Number2447607-85-2
-
分子量405.51
-
分子式C24H23NO3S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=S(=O)(C1=CC=C(C=C1)C)N2C=C(C=3C=CC=CC32)CC=4C=C(C(O)=C(C4)C)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Feng L, et al. Synthesis and Bioevaluation of 3-(Arylmethylene) indole Derivatives: Discovery of a Novel ALK Modulator with Antiglioblastoma Activities[J]. Journal of Medicinal Chemistry, 2023.?
产品手册




关联产品
-
ALK-IN-27
ALK-IN-27 (compound 1) 是一种有效的 ALK 抑制剂。ALK-IN-27 显示出抗肿瘤活性。对于 Ba/F3 CLIP1-LTK 细胞,ALK-IN-27 的 IC50 为 2.7 nM。
-
Lu AF21934
Lu AF21934 是一种脑渗透性、选择性 mGlu4 受体正变构调节剂(IC50:500 nM,人)。
-
JH-VIII-157-02
JH-VIII-157-02 是一种有效的、口服活性的、中枢神经系统可渗透的第二代 ALK G1202R 突变体抑制剂,IC50 为 2 nM。